Alessandro Sannino
Corporate Officer/Principal chez University of Salento
Fortune : 2 410 $ au 31/12/2023
Profil
Alessandro Sannino is the founder of Academica Life Science SRL, which was founded in 2006.
He is currently the Bioslabs Director at the University of Salento since 2000.
Dr. Sannino was a Co-Inventor & Lead Project Scientist at Gelesis, Inc. from 2008 to 2022 and a Lead Project Scientist at Gelesis Holdings, Inc. from 2022 to 2023.
Dr. Sannino holds a doctorate degree from the University of Washington and Università degli Studi di Napoli Federico II.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GELESIS HOLDINGS, INC.
1,64% | 17/03/2023 | 1 204 879 ( 1,64% ) | 2 410 $ | 31/12/2023 |
Postes actifs de Alessandro Sannino
| Sociétés | Poste | Début |
|---|---|---|
| University of Salento | Corporate Officer/Principal | 01/09/2000 |
Anciens postes connus de Alessandro Sannino
| Sociétés | Poste | Fin |
|---|---|---|
| GELESIS HOLDINGS, INC. | Corporate Officer/Principal | 30/10/2023 |
| GELESIS INC | Corporate Officer/Principal | 01/01/2022 |
Academica Life Science SRL
 Academica Life Science SRL Miscellaneous Commercial ServicesCommercial Services Academica Life Science SRL develops biodegradable superabsorbent hydro gels. The company was founded by Luigi Ambrosio, Luigi Nicolais and Alessandro Sannino in 2006 and is headquartered in Naples, Italy | Fondateur | - |
Formation de Alessandro Sannino
| Università degli Studi di Napoli Federico II | Doctorate Degree |
| University of Washington | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GELESIS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Academica Life Science SRL
Academica Life Science SRL Miscellaneous Commercial ServicesCommercial Services Academica Life Science SRL develops biodegradable superabsorbent hydro gels. The company was founded by Luigi Ambrosio, Luigi Nicolais and Alessandro Sannino in 2006 and is headquartered in Naples, Italy | Commercial Services |
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
